QA: Hyperion Therapeutics INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001386858_2013_Hyperion_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001386858, Hyperion Therapeutics INC

  xvar xval
0 AssetsCurrent 51,008,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 49,000
3 remainder_Assets 147,000
4 LiabilitiesCurrent 9,065,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,750,000
7 CostOfGoodsAndServicesSold 10,000
8 SellingGeneralAndAdministrativeExpense 26,657,000
9 ResearchAndDevelopmentExpense 87,281,000
10 remainder_Expenses 27,037,000
11 remainder_Revenues 286,000
12 remainder_NetIncome 1,702,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 51,204,000
1 Liabilities 16,815,000
2 Expenses 140,985,000
3 Revenues 286,000
4 StockholdersEquity 34,389,000
5 NetIncome -138,997,000
6 ComprehensiveNetIncome -138,997,000
7 BaseVar 105,496,000
8 EconomicCapitalRatiobeforeLimitedLiability -1.88
9 EconomicCapitalRatio 1.06

Edgar->Model Mapping

Feature Distribution